Orient Drugs Private Limited

Manufactures and distributes pharmaceutical products according to MoA.

1997 | Malappuram, Kerala (India) | Active
Last Updated:

Orient Drugs Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.91 Cr
  • Company Age 27 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 1.15 Cr
  • Revenue Growth 26.41%
  • Profit Growth 24.44%
  • Ebitda 145.32%
  • Net Worth 5.85%
  • Total Assets 8.43%

About Orient Drugs

Orient Drugs Private Limited (ODPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 March 1997 and has a history of 27 years and 11 months. Its registered office is in Malappuram, Kerala, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.91 Cr.

The company has closed loans amounting to ₹1.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Naseer Kalappaden, Abdu Avulan, Favas Avulan, and Six other members serve as directors at the Company.

Company Details

  • Location

    Malappuram, Kerala, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24231KL1997PTC011301

  • Company No.

    011301

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Mar 1997

  • Date of AGM

    19 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ernakulam

Industry

Pharma

Who are the key members and board of directors at Orient Drugs?

Executive Team (1)

NameDesignationAppointment DateStatus
Abdu Avulan Country flag representing In Managing Director14-Mar-1997Current

Board Members (8)

NameDesignationAppointment DateStatus
Naseer Kalappaden Country flag representing In Director 14-Mar-1997Current
Favas Avulan Country flag representing In Director 26-Dec-2013Current
Fathima Avulan Country flag representing In Director 04-Mar-2016Current
Jameela Badiuzzaman Country flag representing In Director 01-Sep-1997Current
Mumtaz Pothaparambath Country flag representing In Director 01-Sep-1997Current
Zubairali Valiyathodi Country flag representing In Director 04-Mar-2016Current

Financial Performance of Orient Drugs.

Orient Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.41% increase. The company also saw a substantial improvement in profitability, with a 24.44% increase in profit. The company's net worth moved up by a moderate rise of 5.85%.

Orient Drugs revenue growth over time
Orient Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
26.41%
Revenue from Operations
26.32%
Total Assets
8.43%
Profit or Loss
24.44%
Net Worth
5.85%
EBITDA
145.32%

What is the Ownership and Shareholding Structure of Orient Drugs?

Unlock access to Orient Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹1.15 Cr

Charges Breakdown by Lending Institutions

  • South Indian Bank Limited : 0.90 Cr
  • The Federal Bank Ltd. : 0.25 Cr

Latest Charge Details

DateLenderAmountStatus
31 Oct 2007South Indian Bank Limited₹9.00 MSatisfied
02 Aug 2004The Federal Bank Ltd.₹2.50 MSatisfied

How Many Employees Work at Orient Drugs?

Unlock and access historical data on people associated with Orient Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Orient Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orient Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orient Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Orient Drugs

Recent activity within the organization

  • Annual General Meeting

    Orient Drugs Private Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Orient Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.

  • Charges

    A charge registered on 31 Oct 2007 via Charge ID 10075652 with South Indian Bank Limited was fully satisfied on 16 Nov 2022.

  • Director Appointment

    Shibibiyya Mecheri was appointed as a Director was appointed as a Director on 04 Apr 2022 & has been associated with this company since 2 years 11 months .

  • Director Appointment

    Fathima Sheikmoossa Avulan was appointed as a Director was appointed as a Director on 04 Mar 2016 & has been associated with this company since 8 years 11 months .

  • Director Appointment

    Zubairali Valiyathodi was appointed as a Director was appointed as a Director on 04 Mar 2016 & has been associated with this company since 8 years 11 months .

Frequently asked questions

  • What is the Incorporation or founding date of Orient Drugs Private Limited?

    Orient Drugs Private Limited was incorporated on 14 Mar 1997.

  • What is authorized share capital and paid-up capital of Orient Drugs Private Limited?

    The authorized share capital of Orient Drugs Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.91 Cr.

  • Who are the current board members & directors of Orient Drugs Private Limited?

    Currently 9 directors are associated with Orient Drugs Private Limited.

    • Naseer Kalappaden
    • Abdu Avulan
    • Favas Avulan
    • Fathima Sheikmoossa Avulan
    • Jameela Konndla Badiuzzaman
    • Mumtaz Pothaparambath
    • Zubairali Valiyathodi
    • Ummer Thekkepath
    • Shibibiyya Mecheri

  • What is the registered address of Orient Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Orient Drugs Private Limited is 2/254 Orient Tower Vadakkemanna Kodur P.O, India, Malappuram, Kerala, 676504.

  • What is the corporate identification number (CIN) and company number of Orient Drugs Private Limited?

    The corporate identification number (CIN) of Orient Drugs Private Limited is U24231KL1997PTC011301 and the company number is 011301 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Orient Drugs Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Orient Drugs Private Limited has risen by 26.41%.

  • What change has been observed in the net worth of Orient Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Orient Drugs Private Limited has experienced an upsurge of 5.85%.

  • When was the last Balance Sheet of Orient Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Orient Drugs Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors